Gent, Belgium, March 1, 2023

Wheat farmers seeking to increase yields while reducing fertilizer inputs are set to benefit from a new collaboration between Syngenta Crop Protection and Aphea.Bio announced today.

The collaboration aims to accelerate the introduction of a novel biological seed treatment solution across multiple countries in Europe over the next five years, pending regulatory approval. This places a much-needed technology in the hands of farmers seeking to improve the sustainability of their farming operations, and to address challenges arising from an increasingly constrained toolbox of available agricultural technologies as well as evolving consumer demands.

ΛCTIV by Aphea.Bio® is a biostimulant applied as a seed treatment on wheat that is based on beneficial microorganisms. By improving the crop's nutrient use efficiency, it enables as much as five percent higher yields even with reduced fertilizer use.

"We are excited to announce this collaboration with Aphea.Bio, which supports our important ambition of helping feed ever growing populations in more sustainable ways," said Jonathan Brown, Head of Global Seedcare at Syngenta Crop Protection. "It demonstrates our commitment to bringing novel, nutrient use efficiency solutions to growers, helping safeguard yields if nitrogen inputs are reduced. Combined with our leading conventional seed treatment portfolio, ΛCTIV by Aphea.Bio® will offer a unique value proposition in a fast-changing EU landscape."

Isabel Vercauteren, CEO and co-founder of Aphea.Bio, said: "We are excited to launch our first wheat biostimulant in partnership with Syngenta. We are joining forces to build a more sustainable and profitable future for European farmers. And this is just the beginning."

An introduction of ΛCTIV by Aphea.Bio® will represent an additional building block in the strategy to achieving healthy soils by supporting crops through beneficial microorganisms. It furthermore has the potential to contribute to the goal of the European Union's Green Deal to reduce the use of synthetic fertilizers inputs.

About Aphea.Bio

Aphea.Bio is a fully integrated microbial product development company dedicated to food security and ensuring a safe and healthy food chain and is providing novel, science-based solutions to build the agriculture of the future: sustainable, reliable, and profitable. Located in Gent, Belgium, we have a highly dedicated and qualified team of scientist and industry experts. Based on our unique high throughput APEX® R&D platform utilising the untapped microbial space, we have been able to build a broad biostimulant and biocontrol pipeline based on naturally occurring micro-organisms.

We believe that with a fresh and sincere spirit of innovation, result-driven science, and the courage to go off the beaten track, there is fertile ground to develop efficacious biological solutions to help complement or partially replace products in the major chemical indications.

To learn more, visit www.aphea.bio or follow us on LinkedIn at www.linkedin.com/company/aphea-bio.

Aphea Bio
Charlotte Klank
Head of Regulatory Affairs | Communications
[email protected]


Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ("legitimate interest"). However, if you do not wish to receive further information about Aphea.Bio, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement.

Cautionary Statement Regarding Forward-Looking Statements

This document may contain forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Aphea.Bio, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Aphea.Bio assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.

© Aphea.Bio, Technologiepark Zwijnaarde 21, 9052 Zwijnaarde.